Perfect Medical Health Management Limited (HKG:1830)
Hong Kong · Delayed Price · Currency is HKD 1.210
-0.040 (-3.20%)
At close: Feb 13, 2026
HKG:1830 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 993.47 | 1,128 | 1,393 | 1,389 | 1,350 | 1,090 | |
Revenue Growth (YoY) | -23.31% | -19.05% | 0.29% | 2.91% | 23.88% | -12.18% |
Cost of Revenue | 372.79 | 426.71 | 499.22 | 503.07 | 441 | 365.08 |
Gross Profit | 620.68 | 701.15 | 894.12 | 886.19 | 908.97 | 724.69 |
Selling, General & Admin | 122.92 | 147.9 | 167.76 | 157.23 | 189.22 | 155.79 |
Other Operating Expenses | 126.75 | 127.08 | 148.8 | 136.56 | 116.91 | 94.77 |
Operating Expenses | 420.04 | 453.32 | 518.52 | 517.38 | 525.18 | 421.82 |
Operating Income | 200.64 | 247.83 | 375.6 | 368.81 | 383.79 | 302.87 |
Interest Expense | -9.66 | -11.08 | -11.22 | -12.52 | -16.1 | -13.14 |
Interest & Investment Income | 9.83 | 13.29 | 14.54 | 10.9 | 4.88 | 7.99 |
Currency Exchange Gain (Loss) | -2.17 | -1.9 | -0.48 | -0.37 | 2 | 5.13 |
Other Non Operating Income (Expenses) | -0.27 | - | - | - | 0.18 | 0.11 |
EBT Excluding Unusual Items | 198.37 | 248.15 | 378.44 | 366.82 | 374.76 | 302.96 |
Gain (Loss) on Sale of Investments | - | - | - | - | -3.05 | 1.42 |
Gain (Loss) on Sale of Assets | 1.81 | 1.51 | -0.47 | -1.1 | 0.13 | -0.47 |
Other Unusual Items | 2.89 | 2.89 | 5.75 | 25.74 | 6.31 | 54.26 |
Pretax Income | 203.06 | 252.55 | 383.72 | 391.46 | 378.15 | 358.16 |
Income Tax Expense | 37.21 | 46.18 | 73.32 | 75.82 | 72.91 | 73.53 |
Earnings From Continuing Operations | 165.86 | 206.37 | 310.4 | 315.64 | 305.25 | 284.63 |
Minority Interest in Earnings | -5 | 0.53 | 5.4 | - | - | - |
Net Income | 160.86 | 206.9 | 315.8 | 315.64 | 305.25 | 284.63 |
Net Income to Common | 160.86 | 206.9 | 315.8 | 315.64 | 305.25 | 284.63 |
Net Income Growth | -44.58% | -34.48% | 0.05% | 3.40% | 7.24% | -20.97% |
Shares Outstanding (Basic) | 1,256 | 1,256 | 1,256 | 1,249 | 1,231 | 1,169 |
Shares Outstanding (Diluted) | 1,256 | 1,256 | 1,256 | 1,249 | 1,231 | 1,169 |
Shares Change (YoY) | - | -0.01% | 0.57% | 1.51% | 5.27% | 4.27% |
EPS (Basic) | 0.13 | 0.16 | 0.25 | 0.25 | 0.25 | 0.24 |
EPS (Diluted) | 0.13 | 0.16 | 0.25 | 0.25 | 0.25 | 0.24 |
EPS Growth | -44.59% | -34.38% | -0.66% | 1.89% | 2.06% | -24.30% |
Free Cash Flow | 251.03 | 298.23 | 438.84 | 531.52 | 369.34 | 519.64 |
Free Cash Flow Per Share | 0.20 | 0.24 | 0.35 | 0.43 | 0.30 | 0.45 |
Dividend Per Share | 0.129 | 0.165 | 0.251 | 0.253 | 0.248 | 0.250 |
Dividend Growth | -44.16% | -34.26% | -0.79% | 2.02% | -0.80% | -13.79% |
Gross Margin | 62.48% | 62.17% | 64.17% | 63.79% | 67.33% | 66.50% |
Operating Margin | 20.20% | 21.97% | 26.96% | 26.55% | 28.43% | 27.79% |
Profit Margin | 16.19% | 18.34% | 22.66% | 22.72% | 22.61% | 26.12% |
Free Cash Flow Margin | 25.27% | 26.44% | 31.50% | 38.26% | 27.36% | 47.68% |
EBITDA | 263.86 | 315.32 | 454.5 | 455.08 | 460.78 | 357.97 |
EBITDA Margin | 26.56% | 27.96% | 32.62% | 32.76% | 34.13% | 32.85% |
D&A For EBITDA | 63.22 | 67.49 | 78.9 | 86.26 | 76.99 | 55.1 |
EBIT | 200.64 | 247.83 | 375.6 | 368.81 | 383.79 | 302.87 |
EBIT Margin | 20.20% | 21.97% | 26.96% | 26.55% | 28.43% | 27.79% |
Effective Tax Rate | 18.32% | 18.29% | 19.11% | 19.37% | 19.28% | 20.53% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.